挪威

我们是谁

• 1 月 10, 2024

  Study of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency.

• 1 月 9, 2024

  A Study of Nivolumab, Nivolumab Plus Ipilimumab, or Investigator’s Choice Chemotherapy for the Treatment of Participants With Deficient Mismatch Repair (dMMR)/Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (mCRC) ( CheckMate 8HW )

• 1 月 9, 2024

  A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer ( SEAMARK )

• 4 月 5, 2022

  肝脏部分 2/3 移植研究

• 4 月 5, 2022

  A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer (BREAKWATER)

• 4 月 5, 2022

  结直肠癌患者肝移植与化疗的比较

• 4 月 5, 2022

  METIMMOX: Colorectal Cancer METastasis – Shaping Anti-tumor IMMunity by OXaliplatin

• 4 月 5, 2022

  结直肠癌患者使用 BM7PE 免疫毒素的 I/II 期研究